SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
QR Pharma Completes $2.4 Million Seed Financing with Round-Closing Investments from BioAdvance and Angels to Advance Clinical Development of two Alzheimer’s Disease Compounds